Comparison of the in vivo effects of convulsant and optically active hypnotic barbiturates with their effects on the in vitro K+-stimulated release of [3H]acetylcholine.
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001463:Barbiturates / Q000031:analogs & derivatives / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D003292:Convulsants / Q000494:pharmacology*; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008297:Male; D051379:Mice; D010424:Pentobarbital / Q000494:pharmacology; D011188:Potassium / Q000037:antagonists & inhibitors*; D012631:Secobarbital / Q000494:pharmacology; D013237:Stereoisomerism
D001463:Barbiturates; D003292:Convulsants; D006993:Hypnotics and Sedatives; D012631:Secobarbital; C024321:5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate; D010424:Pentobarbital; D000109:Acetylcholine; D011188:Potassium